Go to content
UR Home

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas

URN to cite this document:
DOI to cite this document:
Szeimies, R.-M. ; Morton, M. A. ; Basset‐Seguin, N. ; Calzavara‐Pinton, P. ; Gilaberte, Y. ; Hædersdal, M. ; Hofbauer, G. F. L. ; Hunger, R. E. ; Karrer, S. ; Piaserico, S. ; Ulrich, C. ; Wennberg, A.-M. ; Braathen, L. R.
License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
Date of publication of this fulltext: 26 Jan 2021 18:43

This publication is part of the DEAL contract with Wiley.


Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ), superficial and certain thin basal cell carcinomas. Recurrence rates when standard treatment protocols are used are typically equivalent to existing therapies, although inferior to surgery for nodular basal cell carcinoma. PDT can be used both as lesional and ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons